Suppr超能文献

医疗保险免疫抑制剂覆盖范围与肾移植机会:一项回顾性全国队列研究。

Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study.

机构信息

Division of Nephrology, University of California San Francisco, San Francisco General Hospital, San Francisco, CA, USA.

出版信息

BMC Health Serv Res. 2012 Aug 16;12:254. doi: 10.1186/1472-6963-12-254.

Abstract

BACKGROUND

In December 2000, Medicare eliminated time limitations in immunosuppressant coverage after kidney transplant for beneficiaries age ≥65 and those who were disabled. This change did not apply to younger non-disabled beneficiaries who qualified for Medicare only because of their end-stage renal disease (ESRD). We sought to examine access to waitlisting for kidney transplantation in a cohort spanning this policy change.

METHODS

This was a retrospective cohort analysis of 241,150 Medicare beneficiaries in the United States Renal Data System who initiated chronic dialysis between 1/1/96 and 11/30/03. We fit interrupted time series Cox proportional hazard models to compare access to kidney transplant waitlist within 12 months of initiating chronic dialysis by age/disability status, accounting for secular trends.

RESULTS

Beneficiaries age <65 who were not disabled were less likely to be waitlisted after the policy change (hazard ratio (HR) for the later vs. earlier period, 0.93, p = 0.002), after adjusting for sociodemographic factors, co-morbid conditions, income, and ESRD network. There was no evidence of secular trend in this group (HR per year, 1.00, p = 0.989). Likelihood of being waitlisted among those age ≥65 or disabled increased steadily throughout the study period (HR per year, 1.04, p < 0.001), but was not clearly affected by the policy change (HR for the immediate effect of policy change, 0.93, p = 0.135).

CONCLUSIONS

The most recent extension in Medicare immunosuppressant coverage appears to have had little impact on the already increasing access to waitlisting among ≥65/ disabled beneficiaries eligible for the benefit but may have decreased access for younger, non-disabled beneficiaries who were not. The potential ramifications of policies on candidacy appeal for access to kidney transplantation should be considered.

摘要

背景

2000 年 12 月,医疗保险(Medicare)取消了肾移植后免疫抑制剂覆盖的时间限制,适用于年龄≥65 岁的受益人和残疾受益人。这一变化不适用于因终末期肾病(ESRD)而有资格获得医疗保险但年龄较轻且无残疾的非受益人群体。我们试图在跨越这一政策变化的队列中检查肾移植候补资格的获取情况。

方法

这是一项回顾性队列分析,纳入了美国肾脏数据系统(United States Renal Data System)中 241150 名在 1996 年 1 月 1 日至 2003 年 11 月 30 日期间开始接受慢性透析的 Medicare 受益人。我们使用中断时间序列 Cox 比例风险模型来比较在开始慢性透析后 12 个月内按年龄/残疾状况进入肾移植候补名单的情况,同时考虑到了时间趋势。

结果

未残疾的年龄<65 岁的受益人在政策变更后等待候补名单的可能性较低(与早期相比,晚期的风险比(hazard ratio,HR)为 0.93,p=0.002),调整了社会人口因素、合并症、收入和 ESRD 网络因素后依然如此。该组人群中没有时间趋势的证据(每年的 HR 为 1.00,p=0.989)。在整个研究期间,≥65 岁或残疾的受益人的候补名单可能性稳步增加(每年的 HR 为 1.04,p<0.001),但并未明显受到政策变更的影响(政策变更的即时效应的 HR 为 0.93,p=0.135)。

结论

最近 Medicare 免疫抑制剂覆盖范围的扩大似乎对已经增加的≥65/残疾受益人的候补名单获取机会影响较小,但可能减少了不符合条件的年龄较轻、无残疾受益人的候补名单获取机会。应该考虑政策对候选资格的影响对获取肾移植的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17dc/3470983/d83c53aeaa55/1472-6963-12-254-1.jpg

相似文献

2
Association of Public Reporting of Medicare Dialysis Facility Quality Ratings With Access to Kidney Transplantation.
JAMA Netw Open. 2021 Sep 1;4(9):e2126719. doi: 10.1001/jamanetworkopen.2021.26719.
3
Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation.
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):628-637. doi: 10.2215/CJN.10330917. Epub 2018 Mar 6.
4
Disparities in Access to Timely Waitlisting Among Pediatric Kidney Transplant Candidates.
Pediatrics. 2024 Sep 1;154(3). doi: 10.1542/peds.2024-065934.
5
Transplantation of Patients With Long Dialysis Vintage in the Current Deceased Donor Kidney Allocation System (KAS).
Am J Kidney Dis. 2022 Sep;80(3):319-329.e1. doi: 10.1053/j.ajkd.2022.01.429. Epub 2022 Mar 17.
6
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.
Clin J Am Soc Nephrol. 2013 Dec;8(12):2149-57. doi: 10.2215/CJN.01560213. Epub 2013 Oct 10.
7
Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease.
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):241-250. doi: 10.2215/CJN.09140620. Epub 2021 Jan 26.
8
Disparities in Kidney Transplant Waitlisting Among Young Patients Without Medical Comorbidities.
JAMA Intern Med. 2023 Nov 1;183(11):1238-1246. doi: 10.1001/jamainternmed.2023.5013.
9
Differences in access to cadaveric renal transplantation in the United States.
Am J Kidney Dis. 2000 Nov;36(5):1025-33. doi: 10.1053/ajkd.2000.19106.
10
Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System.
Am J Kidney Dis. 2022 Dec;80(6):707-717. doi: 10.1053/j.ajkd.2022.01.423. Epub 2022 Mar 14.

引用本文的文献

1
Non-medical barriers in access to early steps of kidney transplantation in the United States - A scoping review.
Transplant Rev (Orlando). 2021 Dec;35(4):100654. doi: 10.1016/j.trre.2021.100654. Epub 2021 Sep 22.
3
The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes.
Am J Transplant. 2019 Jul;19(7):1964-1971. doi: 10.1111/ajt.15293. Epub 2019 Mar 5.
4
Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.
Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.
6
Intestine and multivisceral transplantation: current status and future directions.
Curr Gastroenterol Rep. 2015 Jan;17(1):427. doi: 10.1007/s11894-014-0427-8.

本文引用的文献

2
Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.
Clin J Am Soc Nephrol. 2010 Dec;5(12):2323-8. doi: 10.2215/CJN.04220510. Epub 2010 Sep 16.
3
Kidney transplantation in the elderly.
Curr Opin Organ Transplant. 2009 Aug;14(4):380-5. doi: 10.1097/mot.0b013e32832dbd06.
4
Physical function in older candidates for renal transplantation: an impaired population.
Clin J Am Soc Nephrol. 2009 Mar;4(3):588-94. doi: 10.2215/CJN.03860808. Epub 2009 Mar 4.
5
Alternatives to randomisation in the evaluation of public health interventions: design challenges and solutions.
J Epidemiol Community Health. 2011 Jul;65(7):582-7. doi: 10.1136/jech.2008.082602. Epub 2009 Feb 12.
6
Deceased donor kidney transplantation in elderly patients: is there a difference in outcomes?
Transplant Proc. 2008 Dec;40(10):3413-7. doi: 10.1016/j.transproceed.2008.08.127.
7
8
The financial impact of immunosuppressant expenses on new kidney transplant recipients.
Clin Transplant. 2008 Nov-Dec;22(6):738-48. doi: 10.1111/j.1399-0012.2008.00869.x. Epub 2008 Jul 31.
9
Alternatives to the randomized controlled trial.
Am J Public Health. 2008 Aug;98(8):1359-66. doi: 10.2105/AJPH.2007.124446. Epub 2008 Jun 12.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验